resources

Caplin Point Laboratories Ltd.

NSE: CAPLIPOINT

BSE: 524742

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

2,770.10-50.9 (-1.80%)

8 Sep, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Caplin Point Laboratories Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Quarterly Results	—	—	—	—	—	—	—	Mar Jun Sept	Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun
Conference Calls	—	—	—	—	—	—	—	—	—	19May 18Nov	2Jun 16Aug 16Aug 17Nov	16Feb 23May 14Aug 14Nov	14Feb 22May 14Aug 12Nov	21May 19Aug
Presentations	—	—	—	—	—	—	—	—	30Oct	—	—	—	—	5Feb 12Aug

Corporate Announcements and Regulatory Filings

Caplin Point Laboratories Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Newspaper Publication4 Sept 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication for Notice of 35th AGM and E-Voting Information
General4 Sept 2026
Letter To Shareholders
Letter to Shareholders regarding dispatch of 35th AGM Notice and Annual Report for the Financial year 2025-26
Business Responsibility and Sustainability Reporting (BRSR)3 Sept 2026
Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Report for the Financial Year 2025-26
AGM3 Sept 2026
Notice Of The 35Th Annual General Meeting
Notice of the 35th Annual General Meeting of the Company
Reg. 34 (1) Annual Report3 Sept 2026
Reg. 34 (1) Annual Report.
Annual Report for the Financial Year 2025-26
Newspaper Publication2 Sept 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication for convening 35th AGM of the Company through Video Conferencing.
General1 Sept 2026
General Updates
Receipt of Good Manufacturing Practices (GMP) Compliance Certificate by Caplin One Labs Limited (COL), a subsidiary Company, from INVIMA
General21 Aug 2026
General Updates
Completion of Unannounced USFDA Inspection at the facility of Caplin Steriles Limited (Company''s subsidiary)
Analyst / Investor Meet12 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio Recording of Earnings call for the Quarter ended June 30, 2026
Change in Management12 Aug 2026
Announcement under Regulation 30 (LODR)-Change in Management
The Board of Director in its meeting held today, August 12, 2026, approved the appointment of directors.
Dividend12 Aug 2026
Corporate Action-Board approves Dividend
Record date for Final Dividend is September 18, 2026
Outcome of Board Meeting12 Aug 2026
Board Meeting Outcome for Meeting Held On August 12, 2026
Board meeting outcome for meeting held on August 12, 2026
Analyst / Investor Meet30 Jul 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Post-results conference call invite for the quarter ended June 30, 2026 is enclosed herewith.
Board Meeting29 Jul 2026
Board Meeting Intimation for Approval Of Financial Results And Recommendation Of Final Dividend, If Any.
Caplin Point Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve 1. Unaudited financial ....
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201811 Jul 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 for the quarter ended June 30, 2026
Closure of Trading Window27 Jun 2026
Closure of Trading Window
Intimation of closure of Trading Window commencing from July 01, 2026
Newspaper Publication22 Jun 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement for transfer of Unclaimed dividend and shares to IEPF
Reg.24(A)-Annual Secretarial Compliance29 May 2026
Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance report for the year ended March 31, 2026
Analyst / Investor Meet22 May 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Analyst / Investor Meet14 May 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Earnings call for Q4(2025-26)

Frequently Asked Questions

Where can I download the annual report of Caplin Point Laboratories Ltd.?

Annual reports of Caplin Point Laboratories Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Caplin Point Laboratories Ltd.?

Quarterly earnings results and presentations of Caplin Point Laboratories Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Caplin Point Laboratories Ltd. publish earnings call transcripts?

Earnings call transcripts of Caplin Point Laboratories Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Caplin Point Laboratories Ltd.?

Investor presentations and annual day presentations of Caplin Point Laboratories Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Caplin Point Laboratories Ltd.?

Corporate announcements and regulatory filings of Caplin Point Laboratories Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Caplin Point Laboratories Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Caplin Point Laboratories Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Caplin Point Laboratories Ltd.?

The ISIN (International Securities Identification Number) of Caplin Point Laboratories Ltd. is INE475E01026. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Caplin Point Laboratories Ltd. listed?

Caplin Point Laboratories Ltd. is listed on NSE and BSE. The NSE symbol is CAPLIPOINT and the BSE code is -.

Where can I find the shareholding pattern of Caplin Point Laboratories Ltd.?

The quarterly shareholding pattern of Caplin Point Laboratories Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Caplin Point Laboratories Ltd. on Sharpely?

Share price data for Caplin Point Laboratories Ltd. is updated as of 8 Sep 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.